Anja G. Teschemacher
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Long term administration of selective NMDA GluN2B receptor blocker Ro25-6981 attenuates neurodegeneration in mouse model of spinocerebellar ataxia type 1 (SCA1).
Journal: Cell death discovery
Published: January 30, 2026
Memantine suppresses the excitotoxicity but fails to rescue the ataxic phenotype in SCA1 model mice.
Memantine suppresses the excitotoxicity but fails to rescue the ataxic phenotype in SCA1 model mice.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 27, 2023
Adenosine signalling to astrocytes coordinates brain metabolism and function.
Journal: Nature
Published: December 13, 2022
Lactate-Mediated Signaling in the Brain-An Update.
Journal: Brain sciences
Published: November 29, 2022
Indirect Negative Effect of Mutant Ataxin-1 on Short- and Long-Term Synaptic Plasticity in Mouse Models of Spinocerebellar Ataxia Type 1.
Journal: Cells
Published: June 24, 2022
Memantine Disrupts Motor Coordination through Anxiety-like Behavior in CD1 Mice.
Journal: Brain sciences
Published: March 21, 2022
Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM).
Journal: Biomedicines
Published: September 01, 2021
Expression of Microbial Enzymes in Mammalian Astrocytes to Modulate Lactate Release.
Journal: Brain sciences
Published: July 07, 2021
Chronic optogenetic stimulation of Bergman glia leads to dysfunction of EAAT1 and Purkinje cell death, mimicking the events caused by expression of pathogenic ataxin-1.
Journal: Neurobiology of disease
Published: November 15, 2020
Selective optogenetic stimulation of efferent fibers in the vagus nerve of a large mammal.
Journal: Brain stimulation
Published: August 12, 2020
Last Updated: 09/26/2026